仪器共享，破解检测、人才双重瓶颈

Core Viewpoint - The article highlights the successful implementation of a research instrument sharing platform in Jiangsu, which has significantly reduced R&D costs and accelerated the domestic replacement of high-end pharmaceutical excipients [1][2]. Group 1: Instrument Sharing and Collaboration - Jiangsu Southeast Nano Materials Co., Ltd. faced challenges in developing synthetic phospholipid excipients due to a lack of high-end detection equipment and skilled personnel [1]. - The company utilized a shared service platform to collaborate with Jiangsu Food and Drug Vocational College, enabling access to advanced instruments and expertise, thus overcoming dual bottlenecks in detection and talent [1][2]. - The shared model has led to a win-win situation for both the company and the university, enhancing equipment utilization and aligning academic research with industry needs [2]. Group 2: Financial Impact and Policy Support - In 2024, the company received a total of 15,000 yuan in provincial and municipal technology innovation vouchers, effectively reducing R&D testing costs by 50% [2]. - The city has established a comprehensive policy support system, resulting in over 2,400 research instruments being shared, a threefold increase compared to 2024, benefiting more than 200 enterprises [3]. - A dual subsidy mechanism has been implemented, with a total of 2.034 million yuan allocated in subsidies by 2025, aimed at lowering innovation costs for enterprises [3]. Group 3: Future Directions - The city plans to continue promoting the inclusion of enterprise instruments in the network, focusing on key industries such as new pharmaceuticals to enhance full-chain services [3]. - The goal is to establish a benchmark for research instrument sharing in the northern Yangtze River Delta, stimulating innovation and supporting industrial transformation [3].